Navigation Links
Red Wine: One Drink A Day, Keeps Alzheimer's At Bay!

Animal research has once again offered a valuable insight for one of the leading mental illnesses in the World Today – Alzheimer's disease. // Red wine has always hogged a fair share of the limelight, with its perceived benefits to the heart and brain. A recent study seems to suggest that Red wine may be the elixir that mental health researchers have been looking for!

The researchers, from Mount Sinai School of Medicine, studied Mice, which were portraying alterations in the brain akin to Alzheimer's. The mice were fed with doses of Cabernet Sauvignon. It was observed that benefits of red wine was noticeably higher than the effects of ethanol or water; the mice showed remarkable reduction in the trademark alterations associated with memory in Alzheimer's disease.Indeed, Cabernet Sauvignon's contribution is crucial, preventing plaque accumulation in the brain, a distinguishing feature in the development of Alzheimer’s.

Researchers Dr. Giulio Maria Pasinetti and Dr. Jun Wang said "This study supports epidemiological evidence indicating that moderate wine consumption, within the range recommended by the FDA dietary guidelines of one drink per day for women and two for men, may help reduce the relative risk for AD clinical dementia."

Despite this finding, the time is not ripe for a carte blanche prescription of this remedy on humans. Threadbare Clinical trials on humans will prove if the perceived goodness of red-wine on Alzheimer's actually holds water.
SA
'"/>




Page: 1

Related medicine news :

1. Red Wine: Is It A Cure For Periodontal Disease?
2. Kick Smoking with Nicotine Drink
3. Drinking arsenic water leads to cancer
4. Drink grape juice for health
5. Drink milk right now
6. Drink alcohol for intelligence
7. Alcoholism Drug Fails To Prevent Drinking Relapses
8. Weight-Loss Drinks Can Make You Gassy
9. Heavy Drinking Raises Risk of Liver Cancer
10. Drinkers and smokers are at risk
11. Drink more fluids during exercise
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San Francisco dentists, ... cutting-edge Oventus O2Vent technology. As many as 18 million Americans are estimated to ... breathing. Oral appliances can offer significant relief to about 75 percent of people ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... products to meet the demand of today’s consumer and regulatory authorities worldwide. From ... probiotic experts and tested to meet the highest standard. , These products ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... The American ... Excellence to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium ... 8. , In honor of Morris F. Collen, a pioneer in the field of ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: , ... to enable prevention of a major side effect of chemotherapy in children. Cisplatin ... patients. For cisplatin, hearing loss is FDA listed on-label as a dose limiting ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a leader ... a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were ... 11, 2017. , The annual award competition recognizes editorial and design excellence across a ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... Sept. 28, 2017 Hill-Rom Holdings, Inc. (NYSE: ... conference call and webcast on Friday, November 3, 2017, ... and ending at approximately 8:30 a.m. (CDT) / 9:30 ... company,s 2017 financial performance and guidance for 2018, Hill-Rom ... to enhance operational performance, and long-range financial outlook through ...
(Date:9/27/2017)... NEW YORK , Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), ... solutions, today announced that its MyDario product is expected to appear on ... for when The Dr. Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. ... ...
(Date:9/23/2017)... 22, 2017 Janssen Biotech, Inc. (Janssen) announced ... from the U.S. Food and Drug Administration (FDA) for ... for the treatment of moderately to severely active rheumatoid ... data are needed to further evaluate the safety of ... RA. "We ...
Breaking Medicine Technology: